Large genetic map of psychiatric disorders completed

Last Updated on

March 15, 2020 –  An international study published in the journal Cell has described 109 genetic variants associated with eight psychiatric disorders such as autism, ADHD, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder and Tourette syndrome in a total of about 230,000 patients worldwide.  A psychiatric disorder is a behavioral or mental pattern that causes significant distress or impairment of personal functioning. Such features may be persistent, relapsing and remitting, or occur as a single episode. Signs and symptoms that vary widely between specific disorders

About 25% of the world population is affected by some type of psychiatric disease that can alter intellectual ability, behavior, affectivity and social relations. The present study, based on 230,000 affected patients and 500,000 control individuals, analyzes the genetic base shared by eight psychiatric pathologies and defines three groups of highly genetically related disorders. These three groups are a) diseases that respond to compulsive behaviors (anorexia nervosa (AN), obsessive-compulsive disorder), b) mood and psychotic disorders (bipolar disorder (BIP), major depression, and schizophrenia), and c) early-onset neurodevelopmental disorders (autism spectrum disorder (ASD), attention deficit hyperactivity disease (ADHD), and Tourette syndrome).

Those disorders listed in the same group tend to share more genetic risk factors between them than with other groups. Moreover, these groups built on the basis of genetic criteria match with the clinical output, i.e., disease phenotype.

This study did not, however, put emphasis on the genes shared by members of one of particular group of diseases above, but on the genes shared by the highest number of disorders. That is, it focused on those  genetic factors that would at the base of a predisposition for a  ‘sensitive’ brain, that would more likely suffer from any type of psychiatric disorder. And the fact that this could be one or another disorder would depend on specific genetic factors, not forgetting about the environmental factors. Many psychiatric disorders show comorbidities, i.e., they tend to co-occur, sometimes in a sequential manner. Therefore, it is quite likely for a patient to show more than one disorder throughout his/her lifetime.

According to the results, strangely as it may sound, the “Deleted in Colorectal Carcinoma” (DCC) gene, which also has a role und is related to the development of the nervous system, is a risk factor for all eight studied disorders. Also, the RNA binding protein, fox-1 homolog (RBFOX1) gene, which regulates the splicing in many genes, is involved in seven out of the eight disorders considered.

One of the most relevant findings of the study was that those genes that are risk factors for more than one disorder, i.e., genes with pleiotropic effects, are usually active during the second trimester of pregnancy, coinciding with a crucial stage in the development of the nervous system. Overall, the study suggest that genetic influences on psychiatric disorders comprise at least two general classes of genetic loci. The first comprises a set of genes that confer relatively broad liability to psychiatric disorders by acting on early neurodevelopment and the establishment of brain circuitry. These pleiotropic genes, on average, begin to come online by the second trimester of fetal development and exhibit differentially high expression thereafter. The expression and differentiation of this generalized genetic risk into discrete psychiatric syndromes (e.g., ASD, BIP, AN) may then involve direct and/or interactive effects of additional sets of common and rare loci and environmental factors, possibly mediated by epigenetic effects, that shape phenotypic expression via effects on brain structure/function and behavior.

Apart from genomics, the study focused on the analysis of functional aspects of the genetic risk variants such as the impact on gene expression in space (i.e., which organs, specific regions of the brain, tissues and even cells do express the disease genes) and in time (i.e., in what developmental phase of the individual genes are active). Moreover, the study revealed a seemingly odd behaviour in that some genetic variations can act as genetic risk factors in a certain disorder but they have a protecting effect in other cases. Thus, eleven areas of the genome in which the effects are opposed in different pairs of disorders, that is, protection in one case, and susceptibility in the other. This could make sense in some instances in which there would be a genetic variant with contrary effects in ADHD, a disorder usually related to obesity, and anorexia. However, regarding the neurodevelopmental disorders such as autism and schizophrenia, there are genetic variants with opposite effects and others that work in the same direction. In summary then, this observations suggest that the genetics of psychiatric disorders is more complex than thought and needs still some research in order to solve and understand this complex puzzle.

See here a short sequence on psychiatric disorders:

Print Friendly, PDF & Email



Tags: , , , , , , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


@peepso_user_1(Joseph Gut) Aren't we all compulsive, to some degree?
2 weeks ago 2 weeks ago
@peepso_user_7542(Jo Gut) @peepso_user_1(Joseph Gut) We are. Particularly when following and correct obsessively and painstakingly every smallest detail....
@peepso_user_1(Joseph Gut) @peepso_user_7542(Jo Gut) That's it. Then it becomes a disease.
2 weeks ago 2 weeks ago

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Nagano prefecture is home to a group of people affected with a rare genetic neurodegenerative disorder called familial amyloid polyneuropathies (FAP). This disease impacts the gene encoding protein transthyretin (TTR) which is produced in the liver and also eyes. Liver transplants are often a treatment for this disease, but severe eyesight problems such as cloudiness […]
  • Natural sunscreen gene influences how we make vitamin D April 2, 2020
    Genetic variations in the skin can create a natural sunscreen, according to University of Queensland researchers investigating the genes linked with vitamin D.
  • Single mutation leads to big effects in autism-related gene April 2, 2020
    A new study in Neuron offers clues to why autism spectrum disorder (ASD) is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases. The study was conducted […]
  • Lifestyle changes could delay memory problems in old age, depending on our genes April 2, 2020
    Researchers from King's College London have shown that how we respond to changes in nutrients at a molecular level plays an important role in the aging process, and this is directed by some key genetic mechanisms.
  • Geneticists are bringing personal medicine closer for multiracial individuals April 2, 2020
    A new study in Nature Communications proposes a method to extend polygenic scores, the estimate of genetic risk factors and a cornerstone of the personalized medicine revolution, to individuals with multiple ancestral origins. The study was led by Dr. Davide Marnetto from the Institute of Genomics of the University of Tartu, Estonia and coordinated by […]
  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
  • Tissue dynamics provide clues to human disease April 3, 2020
    Scientists in EMBL Barcelona's Ebisuya group, with collaborators from RIKEN, Kyoto University, and Meijo Hospital in Nagoya, Japan, have studied oscillating patterns of gene expression, coordinated across time and space within a tissue grown in vitro, to explore the molecular causes of a rare human hereditary disease known as spondylocostal dysostosis. Their results are published […]
  • Coronavirus: Virological findings from patients treated in a Munich hospital April 3, 2020
    In early February, research teams from Charité - Universitätsmedizin Berlin, München Klinik Schwabing and the Bundeswehr Institute of Microbiology published initial findings describing the efficient transmission of SARS-CoV-2. The researchers' detailed report on the clinical course and treatment of Germany's first group of COVID-19 patients has now been published in Nature*. Criteria may now be […]
  • Case study: Treating COVID-19 in a patient with multiple myeloma April 3, 2020
    A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers. The report, published in Blood Advances, also suggests that blood cancer patients may have atypical COVID-19 symptoms.
  • Indigenous American ancestry may be associated with HER2-positive breast cancer April 3, 2020
    An increased proportion of Indigenous American (IA) ancestry was associated with a greater incidence of HER2-positive breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.